Log in

NASDAQ:RCM - R1 RCM Stock Price, Forecast & News

$13.26
-0.46 (-3.35 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$13.23
Now: $13.26
$13.69
50-Day Range
$12.46
MA: $13.02
$13.84
52-Week Range
$8.77
Now: $13.26
$13.99
Volume769,661 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
Current SymbolNASDAQ:RCM
CUSIP00438V10
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees18,600
Next Earnings Date2/20/2020 (Confirmed)
OptionableNot Optionable

Receive RCM News and Ratings via Email

Sign-up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.


R1 RCM (NASDAQ:RCM) Frequently Asked Questions

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

How were R1 RCM's earnings last quarter?

R1 RCM Inc (NASDAQ:RCM) issued its earnings results on Tuesday, November, 5th. The healthcare provider reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by $0.08. The healthcare provider had revenue of $301.20 million for the quarter, compared to analyst estimates of $302.85 million. The business's quarterly revenue was up 20.3% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.17) EPS. View R1 RCM's Earnings History.

When is R1 RCM's next earnings date?

R1 RCM is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for R1 RCM.

How can I listen to R1 RCM's earnings call?

R1 RCM will be holding an earnings conference call on Thursday, February 20th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for RCM?

4 brokerages have issued twelve-month price targets for R1 RCM's stock. Their forecasts range from $14.00 to $17.00. On average, they anticipate R1 RCM's share price to reach $15.25 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price. View Analyst Price Targets for R1 RCM.

What is the consensus analysts' recommendation for R1 RCM?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for R1 RCM.

Has R1 RCM been receiving favorable news coverage?

News articles about RCM stock have trended somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. R1 RCM earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave headlines about the healthcare provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for R1 RCM.

Are investors shorting R1 RCM?

R1 RCM saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 7,780,000 shares, an increase of 17.3% from the December 31st total of 6,630,000 shares. Based on an average trading volume of 1,160,000 shares, the short-interest ratio is currently 6.7 days. Approximately 8.0% of the shares of the stock are short sold. View R1 RCM's Current Options Chain.

Who are some of R1 RCM's key competitors?

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include Alibaba Group (BABA), NVIDIA (NVDA), Baozun (BZUN), Marvell Technology Group (MRVL), JD.Com (JD), Model N (MODN), Fortinet (FTNT), NMI (NMIH), Perficient (PRFT) and SeaChange International (SEAC).

Who are R1 RCM's key executives?

R1 RCM's management team includes the folowing people:
  • Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 48)
  • Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 49)
  • Mr. Richard B. Evans Jr., Sr. VP, Interim CFO, Corp. Controller & Chief Accounting Officer (Age 51)
  • Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
  • Mr. Corey Perman, Exec. VP of Compliance & Risk

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (2.27%), State Street Corp (2.00%), Bank of New York Mellon Corp (1.92%), Royce & Associates LP (1.15%), Eaton Vance Management (1.14%) and Sectoral Asset Management Inc (1.03%). Company insiders that own R1 RCM stock include Albert Rene Zimmerli and Charles J Ditkoff. View Institutional Ownership Trends for R1 RCM.

Which institutional investors are selling R1 RCM stock?

RCM stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Penn Capital Management Co. Inc., Falcon Point Capital LLC, Point72 Asset Management L.P., Castleark Management LLC, PNC Financial Services Group Inc., Prudential Financial Inc. and Russell Investments Group Ltd.. View Insider Buying and Selling for R1 RCM.

Which institutional investors are buying R1 RCM stock?

RCM stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Mckinley Capital Management LLC Delaware, Eaton Vance Management, Eagle Asset Management Inc., Tealwood Asset Management Inc., Parkman Healthcare Partners LLC, Bank of Montreal Can and Sectoral Asset Management Inc. View Insider Buying and Selling for R1 RCM.

How do I buy shares of R1 RCM?

Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $13.26.


MarketBeat Community Rating for R1 RCM (NASDAQ RCM)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  208 (Vote Outperform)
Underperform Votes:  294 (Vote Underperform)
Total Votes:  502
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: Initial Coin Offering (ICO)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel